Results 131 to 140 of about 15,285 (179)
Atrial fibrillation-induced cardiomyopathy presenting with bilateral intermittent claudication associated with intracardiac thrombi. [PDF]
Inoue R, Watanabe H, Horie T, Ono K.
europepmc +1 more source
The New ESVS Practice Guidelines for Intermittent Claudication are Exactly What We Need. [PDF]
Hicks CW, Veith FJ.
europepmc +1 more source
Comparison between intermittent claudication versus chronic limb-threatening ischemia in peripheral arterial disease: a retrospective multicenter cohort study. [PDF]
Woo HY +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nursing Standard, 2003
Intermittent claudication is a painful, debilitating condition that reduces mobility in those affected and has a detrimental effect on quality of life. It is often the first symptom of peripheral arterial disease. This article explains the aetiology of intermittent claudication, the associated risk factors, vascular assessment and the nursing care ...
openaire +2 more sources
Intermittent claudication is a painful, debilitating condition that reduces mobility in those affected and has a detrimental effect on quality of life. It is often the first symptom of peripheral arterial disease. This article explains the aetiology of intermittent claudication, the associated risk factors, vascular assessment and the nursing care ...
openaire +2 more sources
Intermittent Claudication — Be Conservative
New England Journal of Medicine, 1991Severe peripheral vascular disease is a common disorder that frequently creates substantial morbidity in our aging population.
Jay D Coffman, J D Coffman
exaly +3 more sources
Pharmacotherapy of intermittent claudication
Expert Opinion on Pharmacotherapy, 2001Intermittent claudication (IC) is leg muscle pain, cramping and fatigue brought on by exercise and is the primary symptom of peripheral arterial disease. The goals of pharmacotherapy for IC are to increase the walking capacity/quality of life and to decrease rates of amputation.
openaire +5 more sources
Pentoxifylline for intermittent claudication
2005Intermittent claudication (IC) is a symptom of peripheral arterial occlusive disease (PAD). It is associated with high morbidity and mortality. Pentoxifylline is one of many drugs used to treat IC. Pentoxifylline decreases blood viscosity, improves erythrocyte flexibility, and increases microcirculatory flow and tissue oxygen concentration.Many studies
Kareem, Salhiyyah +4 more
openaire +2 more sources
Prostanoids for intermittent claudication
Cochrane Database of Systematic Reviews, 2013BackgroundPeripheral arterial disease (PAD) is a common cause of morbidity in the general population. While numerous studies have established the efficacy of prostanoids in PAD stages III and IV, the question of the role of prostanoids as an alternative or additive treatment in patients suffering from intermittent claudication (PAD II) has not yet been
Lindsay, Robertson, Alina, Andras
openaire +2 more sources

